Tables
- Table 1.1 Phases of development of guideline modules
- Table 2.2 Body of evidence matrix
- Table 2.3 Definitions of NHMRC grades for recommendations
- Table B.1 Transfusion risks and benefits
- Table B.2 Transfusion risks in perspective
- Table B.3 Calman chart (United Kingdom risk per one year)
- Table D.1 Search dates and cut-off points
- Table D.2 Populations, sub groups and stratification criteria
- Table E.1 Blood component product information and dosage – Australia
- Table E.2 Blood component product information and dosage – New Zealand